Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
about
Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventionsRole of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heartThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.Thrombospondin-1 and angiotensin II inhibit soluble guanylyl cyclase through an increase in intracellular calcium concentration.Regulation of cerebral arterial BKCa channels by angiotensin II signaling in adult offspring exposed to prenatal high sucrose dietsAngiotensin II receptors and drug discovery in cardiovascular disease.Differential expression of microRNAs in ischemic heart disease.High-salt diets during pregnancy affected fetal and offspring renal renin-angiotensin systemHigh Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats.Effects of rosuvastatin on expression of angiotensin-converting enzyme 2 after vascular balloon injury in rats.Antenatal betamethasone exposure is associated with lower ANG-(1-7) and increased ACE in the CSF of adult sheepAT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity.Isolation and biochemical characterization of bradykinin-potentiating peptides from Bitis gabonica rhinoceros.Heart function and thoracic aorta gene expression profiling studies of ginseng combined with different herbal medicines in eNOS knockout mice.A novel rodent model of pregnancy complications associated with genetically determined angiotensin converting enzyme (ACE) activity.(-)-Epigallocatechin-3-gallate inhibits human angiotensin-converting enzyme activity through an autoxidation-dependent mechanism.
P2860
Q26996467-19654A5F-AFC6-4BD6-8C0D-6498BE5BB76EQ28079603-E961E2B8-97EE-454D-9DF3-ED36B96C12E3Q30486745-1A8FE40B-002C-4159-8DB4-04DE537780D5Q30503997-CC938E6E-182D-42F9-A2B8-6CC46120C691Q33820422-998BA795-506A-4B98-A2D1-42FDF66414A6Q34496676-41AF0E70-4250-4859-979F-96FFD9E02210Q35108100-E51D5E36-3ACB-4B38-9FA7-5E4B4C86B25AQ35522300-CA4B206B-DD21-4F1C-A3F0-69BEB9B88D68Q36208883-75D1A1CF-DA99-43D3-ADE5-0048FB097AE2Q37001571-D6868F05-66C7-457A-94C9-465B97F7014FQ37235018-665D7E6B-B55C-476B-A26C-8363528FE24EQ37510211-15762916-911C-43DB-8BA8-6A7F5F94BA21Q41036113-CF6908C9-5D00-4A0D-AB14-26CD0AE3D2C5Q47128850-13C48194-5550-4768-9FFD-F7083C0DEEC6Q49842182-0F5FAE79-7809-41C7-A60E-EAE7018A5CF4Q50980349-17B0C8E8-1357-4BEB-998F-BC2F0717C0A5
P2860
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@ast
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@en
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@nl
type
label
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@ast
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@en
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@nl
prefLabel
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@ast
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@en
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases.
@nl
P2093
P2860
P1433
P1476
Angiotensin-converting enzymes and drug discovery in cardiovascular diseases
@en
P2093
P2860
P304
P356
10.1016/J.DRUDIS.2010.02.003
P50
P577
2010-02-17T00:00:00Z